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Introduction. Unintentional non-adherence most often means forgetting, whereas intentional non-adherence involves 
a conscious choose to stop taking a medicine. However, dual process models of cognition suggest that automatic 
unconscious processes can underpin conscious, apparently intentional, choices. That is, our prior experiences with 
medicines can produce attitudes and associations that we are not necessarily consciously aware of, and that these 
may be key predictors of intentional choice.  
Aims. To determine whether implicit attitudes contribute unique prediction to both medicines adherence and to self-
medication. 
Methods. Study 1 was a prospective cohort study, with a random sample of 152 people aged 18-65 recruited from the 
Dunedin telephone directory. Each participant completed a series of questionnaires at Time 1, including an implicit 
measure of attitudes towards medicines (Green et al, in press). They were then followed up each day for 30 days and 
asked if they had experienced symptoms, and if so, what actions they took in response. Study 2 was a cross-sectional 
study, with a convenience sample of 74 participants. Participants completed implicit and explicit measures of attitudes 
towards medicines as well as measures of adherence. 
Results. In Study 1, having a negative attitude towards conventional medicines predicted great use of self-medication, 
O.R. 0.51, P < .05. In Study 2, positive attitudes towards conventional medicines were associated with higher levels of 
adherence, r (74) = .45, P < .01. 
Discussion. The implicit measure of attitudes to medicines was a strong predictor of both self-medication and 
medicines adherence, even when controlling for explicit attitude. Therefore, interventions to improve adherence and 
promote rational self-medication need to consider the role of automatic processes alongside conscious choice. 
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Introduction. Drug use during pregnancy is common; yet data to support safety are mainly case reports and 
retrospective studies. There is also growing evidence for harmful fetal effects when treatment of certain maternal 
conditions is inadequate. Seeking information is a coping strategy and can assist with decision-making.  
Aim. This study aimed to identify the medicines information needs of women across pregnancy stages and explore 
whether their questions could be justified by actual pregnancy risk.  
Methods. We conducted a retrospective, mixed method study of pregnancy-related calls to an Australian consumer 
medicines call centre, NPS Medicines Line (September 2002-June 2010). Call characteristics were compared for 
pregnancy (n = 4,573) and non-pregnancy (n = 118,547) questions. Drugs of interest, motivations to call and question 
themes were analysed across pregnancy stages, with medicines assessed for risk, using the Australian categorisation 
system for prescribing medicines in pregnancy. Call narratives were explored for stage-specific themes. 
Results. Pregnancy-related enquiries were prompted more often by conflicting or inadequate information and request 
for second opinion. Most questions concerned safety. Psychotropic medication and fertility were strong drivers to 
seek information in preconception. Everyday illnesses and self-medication with Over-The-Counter products were of 
increasing concern as pregnancy progressed, with medicines classified as ‘safe’ accounting for 34% of questions.  
Conclusion. Analysis of real world, pregnancy-related questions demonstrates that women are concerned about safe 
drug use in pregnancy and are likely to overestimate risk. Health care professionals should proactively address drug 
information gaps of women’s pregnancy stage-specific information needs during routine consultations. 
